| Dr Cheryl Goble Freeman, DDS | |
|
134 Davis St, Asheboro, NC 27203-5469 | |
| (336) 625-3292 | |
| (336) 629-3781 |
| Full Name | Dr Cheryl Goble Freeman |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 134 Davis St, Asheboro, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689676330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 6138 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cheryl Goble Freeman, DDS 327 Walnut Dr, Asheboro, NC 27205-9497 Ph: () - | Dr Cheryl Goble Freeman, DDS 134 Davis St, Asheboro, NC 27203-5469 Ph: (336) 625-3292 |
News Archive
Plantar fasciitis is the most frequent cause of chronic heel pain, leaving many sufferers unable to put their best foot forward for months at a time. Now a Mexican study suggests that physicians should turn to Botox rather than steroids to offer patients the fastest road to recovery.
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
By analyzing 442 samples from three groups of children and adults with acute myeloid leukemia (AML), researchers have identified new immune classes of the disease that predict the likelihood of drug resistance and positive responses to immunotherapy.
With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.
› Verified 2 days ago
Jyotica Ahuja, Dentist Medicare: Not Enrolled in Medicare Practice Location: 525 Oakmont Dr, Asheboro, NC 27205 Phone: 336-510-9805 | |
Dr. David Ben Malin, DDS Dentist Medicare: Medicare Enrolled Practice Location: 300 Foust St, Asheboro, NC 27203 Phone: 336-629-3131 | |
Dr. Kenitra Charmaine Richardson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 308 Brewer St, Asheboro, NC 27203 Phone: 336-610-7000 | |
Dr. Janice Ko, DDS Dentist Medicare: Medicare Enrolled Practice Location: 350 N Cox St Ste 18, Asheboro, NC 27203 Phone: 336-625-4700 | |
Dr. Jason Macik, DDS Dentist Medicare: Medicare Enrolled Practice Location: 308 Brewer St, Asheboro, NC 27203 Phone: 336-610-7000 | |
Dr. Alton Anderson Ii, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 422 N Church St, Asheboro, NC 27203 Phone: 336-625-1319 | |
Dr. Oliver Yun, DMD Dentist Medicare: Medicare Enrolled Practice Location: 350 N Cox St Ste 18, Asheboro, NC 27203 Phone: 336-625-4216 |